Regulation
Argus Cognitive’s paediatric autism diagnostic secures FDA clearance
Argus Cognitive received FDA clearance for Neurora, a diagnostic tool designed to support clinical assessment of autism in pediatric patients. The device is intended to complement rather than replace clinician judgment in diagnosis.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network